Bukkawar Heart & Critical Care Hospital & Research Institute Profile
Key Indicators
- Authorised Capital ₹ 2.50 M
as on 05-07-2024
- Paid Up Capital ₹ 1.03 M
as on 05-07-2024
- Company Age 14 Year, 2 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 1.12 Cr
as on 05-07-2024
About Bukkawar Heart & Critical Care Hospital & Research Institute
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 2.50 M and a paid-up capital of Rs 1.03 M.
The company currently has active open charges totaling ₹1.12 Cr.
Vishakha Bukkawar, Sheetal Bukkawar, and Amrish Bukkawar serve as directors at the Company.
- CIN/LLPIN
U73100MH2010PTC209053
- Company No.
209053
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
15 Oct 2010
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Mumbai
Industry
Company Details
- Location
Chandrapur, Maharashtra, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Bukkawar Heart & Critical Care Hospital & Research Institute?
Board Members(3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Vishakha Bukkawar  | Director | 01-Apr-2011 | Current |
| Sheetal Bukkawar | Director | 01-Apr-2011 | Current |
| Amrish Bukkawar | Director | 15-Oct-2010 | Current |
Financial of Bukkawar Heart & Critical Care Hospital & Research Institute.
Bukkawar Heart & Critical Care Hospital & Research Institute Private Limited, for the financial year ended 2017, experienced no change in revenue, with a 0% increase. The company also saw a no change in profitability, with a 0% increase in profit. The company's net worth witnessed no change by increase of 0%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets | |||||||
| Profit or Loss | |||||||
| Net Worth | |||||||
| EBITDA |
What is the Ownership and Shareholding Structure of Bukkawar Heart & Critical Care Hospital & Research Institute?
In 2017, Bukkawar Heart & Critical Care Hospital & Research Institute had a promoter holding of 99.86% and a public holding of 0.14%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Others Creation Date: 28 Apr 2023 | ₹1.12 Cr | Open |
How Many Employees Work at Bukkawar Heart & Critical Care Hospital & Research Institute?
Bukkawar Heart & Critical Care Hospital & Research Institute has a workforce of 29 employees as of Apr 06, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Bukkawar Heart & Critical Care Hospital & Research Institute, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Bukkawar Heart & Critical Care Hospital & Research Institute's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
